A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

1. Kuemmel, S.
2. Campone, M.
3. Loirat, D.
4. Lopez, R.L.
5. Thaddeus Beck, J.
6. de Laurentiis, M.
7. Im, S.-A.
8. Kim, S.-B.
9. Kwong, A.
10. Steger, G.G.
11. Adelantado, E.Z.
12. Duhoux, F.P.
13. Greil, R.
14. Kuter, I.
15. Lu, Y.-S.
16. Tibau, A.
17. Özgüroğlu, M.
18. Scholz, C.W.
19. Singer, C.F.
20. Vega, E.
21. Wimberger, P.
22. Zamagni, C.
23. Couillebault, X.-M.
24. Fan, L.
25. Guerreiro, N.
26. Mataraza, J.
27. Sand-Dejmek, J.
28. Chan, A.
29. Show all authors +